Palbociclib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.PALBOCICLIB (pal boe SYE klib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat breast cancer. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.Palbociclib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Palbociclib Nitroso Impurity 2 CAS NO:NA Chemically represented as N-(6-Acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)-N-(5-(4-nitrosopiperazin-1-yl)pyridin-2-yl)nitrous amide . Synchemia is the leading manufacturing and exporter of Palbociclib Nitroso Impurity 2. We supply Palbociclib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142948 |
| CAS No | NA |
| Mol.F. | C19H27ClN4O5S |
| Mol.Wt. | 459 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142949 |
| CAS No | NA |
| Mol.F. | C19H27ClN4O5S |
| Mol.Wt. | 459 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142950 |
| CAS No | NA |
| Mol.F. | C19H26ClN5O6S |
| Mol.Wt. | 488 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142951 |
| CAS No | NA |
| Mol.F. | C16H20ClN5O2 |
| Mol.Wt. | 349.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142952 |
| CAS No | NA |
| Mol.F. | C16H21ClN4O2 |
| Mol.Wt. | 336.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142953 |
| CAS No | NA |
| Mol.F. | C8H10N4O5S2 |
| Mol.Wt. | 306.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142954 |
| CAS No | NA |
| Mol.F. | C7H5Cl2N5O6S2 |
| Mol.Wt. | 390.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142955 |
| CAS No | NA |
| Mol.F. | C7H6Cl2N4O5S2 |
| Mol.Wt. | 361.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142956 |
| CAS No | NA |
| Mol.F. | C15H15Cl2N7O9S4 |
| Mol.Wt. | 636.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142957 |
| CAS No | NA |
| Mol.F. | C7H5ClN4O5S2 |
| Mol.Wt. | 324.71 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142958 |
| CAS No | NA |
| Mol.F. | C6H4ClN5O5S2 |
| Mol.Wt. | 325.70 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142959 |
| CAS No | NA |
| Mol.F. | C7H6ClN3O3S |
| Mol.Wt. | 247.65 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142960 |
| CAS No | NA |
| Mol.F. | C12H16N2O3 |
| Mol.Wt. | 236.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142961 |
| CAS No | NA |
| Mol.F. | C14H20N2O6 |
| Mol.Wt. | 312.32 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142962 |
| CAS No | NA |
| Mol.F. | C27H37N3O7 |
| Mol.Wt. | 515.61 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142963 |
| CAS No | NA |
| Mol.F. | C14H18N2O5 |
| Mol.Wt. | 294.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |